The company has 180 days to regain compliance with Nasdaq’s minimum bid price The company has 180 days to regain compliance with Nasdaq’s minimum bid price

Bitcoin treasury Kindly MD faces potential delisting after Nasdaq price notice

The company has 180 days to regain compliance with Nasdaq’s minimum bid price requirement after its shares traded below $1 for 30 consecutive business days.

Bitcoin treasury company Kindly MD has received a Nasdaq notice after its shares traded below the exchange’s $1 minimum bid price for 30 consecutive business days, starting a six-month window to regain compliance or risk being delisted.

The notice, which was issued Wednesday, does not immediately affect trading, but gives the company until June 8, 2026, to lift its share price above $1 for at least 10 consecutive trading days, according to a regulatory filing from the Securities and Exchange Commission (SEC).

If the company fails to regain compliance within the initial 180-day period, it may seek an additional extension by transferring its listing to the Nasdaq Capital Market, subject to meeting other listing requirements, the according to the filing. Nasdaq could ultimately delist the shares if the company fails to satisfy the bid price rule or pursue available remedies.

Read more

Market Opportunity
CreatorBid Logo
CreatorBid Price(BID)
$0.02775
$0.02775$0.02775
-3.34%
USD
CreatorBid (BID) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.